Author/Authors :
Dall’Oca, C. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona , Cengarle, M. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona , Costanzo, A. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona , Giannini, N. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona , Vacchiano, A. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona , Magnan, B. Clinica Ortopedica - Azienda Ospedaliero Universitaria Integrata, Verona
Abstract :
Early knee osteoarthritis and chondral lesions are a common cause of disability in younger pa-tients. Surgical options, such as microfractures, ACI and OAT, provide good, but not fully satisfying, out-comes. Recent advance in biological knowledge introduced two different methodological approaches of de-livering growth factors and stem cells into the articular environment. Platelet-Rich Plasma and Mesenchimal Stem Cells are supposed to change the way to approach early knee osteoarthritis and chondral lesions, though their indications and limits are yet to be determined. (www.actabiomedica.it)
Keywords :
knee OA , osteochondral lesion , MSCs , ASCs , PRP , stem cells